Correlation Between Verastem and Biovaxys Technology
Can any of the company-specific risk be diversified away by investing in both Verastem and Biovaxys Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verastem and Biovaxys Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verastem and Biovaxys Technology Corp, you can compare the effects of market volatilities on Verastem and Biovaxys Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verastem with a short position of Biovaxys Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verastem and Biovaxys Technology.
Diversification Opportunities for Verastem and Biovaxys Technology
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Verastem and Biovaxys is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Verastem and Biovaxys Technology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biovaxys Technology Corp and Verastem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verastem are associated (or correlated) with Biovaxys Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biovaxys Technology Corp has no effect on the direction of Verastem i.e., Verastem and Biovaxys Technology go up and down completely randomly.
Pair Corralation between Verastem and Biovaxys Technology
Given the investment horizon of 90 days Verastem is expected to generate 1.86 times less return on investment than Biovaxys Technology. But when comparing it to its historical volatility, Verastem is 1.46 times less risky than Biovaxys Technology. It trades about 0.03 of its potential returns per unit of risk. Biovaxys Technology Corp is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 11.00 in Biovaxys Technology Corp on September 2, 2024 and sell it today you would lose (5.97) from holding Biovaxys Technology Corp or give up 54.27% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Verastem vs. Biovaxys Technology Corp
Performance |
| Timeline |
| Verastem |
| Biovaxys Technology Corp |
Verastem and Biovaxys Technology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Verastem and Biovaxys Technology
The main advantage of trading using opposite Verastem and Biovaxys Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verastem position performs unexpectedly, Biovaxys Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biovaxys Technology will offset losses from the drop in Biovaxys Technology's long position.The idea behind Verastem and Biovaxys Technology Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Biovaxys Technology vs. Rigel Pharmaceuticals | Biovaxys Technology vs. Geron | Biovaxys Technology vs. Verastem | Biovaxys Technology vs. Immutep Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |